Latest Hydrix (Asx:Hyd) News

Page 1 of 1
Hydrix Limited reports a robust quarter with $3.35 million in sales, a 7% revenue increase, and a strong international client base, while advancing US market ventures.
Ada Torres
Ada Torres
28 Oct 2025
Hydrix Limited will have its trading suspension lifted on 13 October 2025 following the release of its audited financial statements for FY2025. Investors await clarity on the company’s financial health as it returns to the ASX.
Sophie Babbage
Sophie Babbage
10 Oct 2025
Hydrix Limited delays its FY25 financial statements due to a pending independent valuation of its Wavewise Analytics shareholding, triggering an automatic trading suspension from 1 October 2025.
Ada Torres
Ada Torres
30 Sept 2025
Hydrix Limited has responded to an ASX query following a sudden surge in its share price and trading volume, denying any undisclosed material information and reaffirming compliance with listing rules.
Sophie Babbage
Sophie Babbage
24 Sept 2025
Hydrix Limited narrowed its FY2025 loss to $2.92 million, driven by significant cost reductions and steady revenue from expanding international medtech clients. Despite ongoing challenges in sales cycles and funding, the company remains focused on innovation and strategic investments.
Ada Torres
Ada Torres
29 Aug 2025
Hydrix Limited reports steady June quarter revenues with a 10% rise from the prior quarter, supported by new contract wins and a robust $40 million project pipeline.
Ada Torres
Ada Torres
31 July 2025
Hydrix Limited reports improved operating performance in Q3 FY25, buoyed by FDA clearance of its Gyder Surgical Hip Navigation system and a reduced cash operating loss, while managing tight liquidity with shareholder support.
Ada Torres
Ada Torres
30 Apr 2025
Gyder Surgical, backed by Hydrix Ventures, has secured FDA 510(k) clearance for its innovative GYDER Hip System, opening the door to the lucrative U.S. market and increasing Hydrix’s investment value.
Ada Torres
Ada Torres
10 Feb 2025
Hydrix Limited reports back-to-back profitable quarters driven by strong margins and cost efficiencies, underpinned by a robust $40 million sales opportunity pipeline in cardiac and medtech sectors.
Ada Torres
Ada Torres
28 Jan 2025
Hydrix Limited has extended its contract with Paul Hartmann AG, adding $2.8 million in revenue and reinforcing its international growth strategy.
Ada Torres
Ada Torres
23 Jan 2025